Social-Psychological Intervention to Improve Adherence to HAART

NCT ID: NCT00716040

Last Updated: 2008-07-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

121 participants

Study Classification

INTERVENTIONAL

Study Start Date

2008-03-31

Study Completion Date

2008-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

All eligible patients will be invited to use electronic monitoring of medication (MEMS) during the next six months. After two months with MEMS the enrolled patients will be randomized to intervention group or to control group. The intervention group will be submitted to four social-psycho sessions with a pre-trained health professional. The control group will receive the usual care of the health service.

The study will compare the rate of adherence to antiretroviral therapy between the intervention group and the control group. The duration of the study will be of six months. The analysis will be based on "intention-to-treat.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

AIDS HIV Infections

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

AIDS treatment HAART adherence intervention

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

The intervention group will be submitted to four social-psychological individual sessions with a pre-trained health professional.

Group Type EXPERIMENTAL

Social-psycho intervention to improve adherence to HAART

Intervention Type BEHAVIORAL

The intervention focus on the notion of scenes and scenarios to examine and discussing the experience of taking ARV medicines. In principle, such an approach provides a tool for conscientization, action and the invention of novel group and individual repertoires that may result in individual mobilization for improving adherence to treatment and reducing his/her vulnerability.

Control

The control group will be submitted to the usual care of the health service.

Group Type OTHER

Usual care

Intervention Type OTHER

The control group will be submitted to the usual care of the health service

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Social-psycho intervention to improve adherence to HAART

The intervention focus on the notion of scenes and scenarios to examine and discussing the experience of taking ARV medicines. In principle, such an approach provides a tool for conscientization, action and the invention of novel group and individual repertoires that may result in individual mobilization for improving adherence to treatment and reducing his/her vulnerability.

Intervention Type BEHAVIORAL

Usual care

The control group will be submitted to the usual care of the health service

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients aged more than 18 years old, with detectable viral load and more than six months under HAART

Exclusion Criteria

* Pregnant women
* Patients participating in other trials
* Patients in treatment for hepatitis and for active opportunistic infection
* Patients with mental or physical condition which do not allow their attendance to the health service
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fundação de Amparo à Pesquisa do Estado de São Paulo

OTHER_GOV

Sponsor Role collaborator

University of Sao Paulo

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Faculdade de Medicina da Universidade de São Paulo

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Maria Ines B Nemes, PhD

Role: PRINCIPAL_INVESTIGATOR

Faculty of Medicine -University of Sao Paulo

Ernani T Santa Helena, PhD

Role: STUDY_DIRECTOR

Regional University of Blumenau

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Centro de Referência e Treinamento DST/AIDS

São Paulo, São Paulo, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

References

Explore related publications, articles, or registry entries linked to this study.

Basso CR, Helena ET, Caraciolo JM, Paiva V, Nemes MI. Exploring ART intake scenes in a human rights-based intervention to improve adherence: a randomized controlled trial. AIDS Behav. 2013 Jan;17(1):181-92. doi: 10.1007/s10461-012-0175-4.

Reference Type DERIVED
PMID: 22527264 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

FAPESP 2006-61277-6

Identifier Type: -

Identifier Source: org_study_id